Current issues in the management of advanced squamous cell carcinoma of the penis

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 6, 2003, Pages 431-438

  Syed, Samira ^a   Eng, Tony Y ^a   Thomas Jr , Charles R ^a   Thompson, Ian M ^b   Weiss, Geoffrey R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Chemotherapy; Novel agents; Penile cancer; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; IRIDIUM 192; METHOTREXATE; MITOMYCIN C; PROTEIN P53; VINCRISTINE;

ADVANCED CANCER; ANTIBIOTIC THERAPY; ARTICLE; BODY FLUID; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CIRCUMCISION; CLINICAL TRIAL; DOSIMETRY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SCREENING; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MONOTHERAPY; MORBIDITY; PENIS AMPUTATION; PENIS CARCINOMA; PHIMOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENTINEL LYMPH NODE BIOPSY; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR VOLUME; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; MALE; PENILE NEOPLASMS; PROGNOSIS;

EID: 2142755817     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(03)00058-9     Document Type: Article

References (86)

1. Herr H.W., Dalbagni G., Bajorn D.F., Shipley W.U. Cancer of the urethra and penis. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer, Principles and Practice of Oncology. 6th ed:2000;Lippincott Williams & Wilkins, Philadelphia, PA
2. Pettaway C.A., Balbay M.D., Grossman H.B. Penis and Urethra Clin Oncol. 2nd ed:2000;Churchill Livingstone, Oxford, UK
3. Krieg R., Hoffman R. Current management of unusual genitourinary cancers. Part 1: Penile cancer. Oncology (Huntington). 13:1999;1347-1352
4. Stadler W.M., Vogelzang N.J., Elwell C.M., Jones W.G. Penile Cancer. Comprehensive Textbook of Genitourinary Oncology. 2nd ed:2000;Lippincott Williams & Wilkins, Philadelphia, PA
5. Zouhair A., Coucke P.A., Jeanneret W., et al. Radiation therapy alone or combined surgery and radiation therapy in squamous cell carcinoma of the penis? Eur J Cancer. 37:2001;198-203
6. Demitsu T., Nagato H., Nishimaki K., et al. Melanoma in situ of the penis. J Am Acad Dermatol. 42:2000;386-388
7. De Bree E., Sanidas E., Tzardi M., et al. Malignant melanoma of the penis. Eur J Surg Oncol. 23:1997;277-279
8. Layfield L.J., Liu K. Mucoepidermoid carcinoma arising in the glans penis. Arch Pathol Lab Med. 124:2000;148-151
9. Corsi A., Perugia G., De Matteis A. Epitheliod sarcoma of the penis. Clinicopathologic study of a tumor with myogenic features and review of the literature concerning this unusual location. Pathol Res Pract. 195:1999;441-448
10. Webber R.J., Alsaffar N., Bissett D., Langlois N.E.I. Angiosarcoma of the penis. Urology. 51:1998;130-131
11. Fujimoto N., Hiraki A., Ueoka H., et al. Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported cases. Lung Cancer. 34:2001;149-152
12. Soria J.C., Fizazi K., Piron F.D., et al. Squamous cell carcinoma of the penis multivariate analysis of prognostic factors and natural history in a monocentric study with a conservative policy. Annals of Oncol. 8:1997;1089-1098
13. Tsen H.F., Morgenstern H., Mack T., et al. Risk factors for penile cancer results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 12:2001;267-267
14. Heyns C.F., van Vollenhoven P., Steenkamp J.W., et al. Cancer of the penis - A review of 50 patients. S Afr J Surg. 35:1997;120-124
15. Rubin M.A., Kleter B., Zhou M., et al. Detection and typing of human papillomavirus DNA in penile carcinoma. Am J Pathol. 159:2001;1211-1218
16. Eifel P.J., Berek J.S., Thigpen J.T. Cancer of the cervix, vagina and vulva. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer, Principles and Practice of Oncology. 6th ed:2000;1526-1573 Lippincott Williams & Wilkins, Philadelphia, PA
17. Levi J.E., Rahal P., Sarkis A.S., Villa L.L. Human Papillomavirus DNA and p53 status in penile carcinoma. Int J Cancer. 76:1998;779-783
18. Picconi M.A., Ejan A.M., Distefano A.L., et al. Human papillomavirus DNA in penile carcinoma in Argentina analysis of primary tumors and lymph nodes. J Med Virol. 61:2000;65-69
19. Gregoire L., Cubilla A.L., Reuter V.E., Haas G., Lancaster W.D. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl. Cancer Inst. 87:1995;1705-1709
20. Iwasawa A., Kumamoto Y., Fujinaga K. Detection of human papillomavirus DNA in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol. 149:1993;59-63
21. Cupp M.R., Malek R.S., Goellner J.R., Smith T., Epsy M.J. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol. 154:1995;1024-1029
22. Barbosa M.S., Vass W.C., Lowy D.R., Schiller J.T. In vitro biological activities of the E6 and E7 genes vary among the HPVs different oncogenic potential. J Virol. 65:1991;292-298
23. Varma V.A., Sanchez-Lanier M., Unger E.R., et al. Association of human papillomavirus with penile carcinoma. Hum Pathol. 22:1991;908-913
24. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79
25. Munger K., Phelps W.C., Bubb V., Howley P.M., Schiegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. 63:1989;4417-4421
26. Rajan S., Norman A.R., Steel G.G., Horwich A. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiation Oncol Biol Phys. 38:1997;713-722
27. Demkow T. The Treatment of Penile Carcinoma experience in 64 cases. Int Urol and Neph. 31:1999;525-531
28. Mukamel E., deKernion J.B. Early versus delayed lymph-node dissection versus no lymph-node dissection in carcinoma of the penis. Urol Clin of North Am. 14:1987;707-711
29. Solsona E., Iborra I., Rios J.V., et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol. 22:1992;115-118
30. Villavicencio H., Rubio-Briones J., Regalado R., et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol. 32:1997;442-447
31. Heyns C.F., van Vollenhoven P., Steenkamp J.W., Allen F.J., Van Velden D.J. Carcinoma of the penis - appraisal of a modified tumor staging system. Br J Urol. 80:1997;307-312
32. Hatzichristou D.G., Apostolidis A., Tzortzis V., Hatzimouratidis K., Ioannides E., Yannakoyorgos K. Glansectomy an alternative surgical treatment for Buschke-Lowenstein tumors of the penis. Urol. 57:2001;966-969
33. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol. 72:1993;817-819
34. Wiener J.S., Effert P.J., Humphrey P.A., Yu L Liu E.T., Walther P.J. Prevalence of Human Papillomavirus types 16 and 18 in squamous cell carcinoma of the penis Retrospective Analysis of Primary and Metastatic Lesions by Differential Polymerase Chain Reaction. Int J Cancer. 50:1992;694-701
35. Bezerra A.L., Lopes A., Santiago G.H., Ribeiro K.C., Latore M.R.D.O., Villa L.L. Human Papillomavirus as a Prognostic Factor in Carcinoma of the Penis. Cancer. 91:2001;2315-2321
36. Lopes A., Licio A.R., Pinto C.A., et al. p53 as a New Prognostic Factor in Penile carcinoma Analysis of 82 Patients Treated with Amputation and Bilateral Lymphadenectomy. Ann Surgical Oncol. 9:2002;S-33. (Abstr 82)
37. Martins A.C.P., Faria S.M., Cologna A.J., Suaid H.J., Tucci S. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol. 167:2002;89-93
38. Chaudhary A.J., Ghosh S., Bhalavat R.L., et al. Interstitial brachytherapy in carcinoma of the penis. Strahlenther Onkol. 175:1999;17-20
39. Andriole G.L., Miller D.C., Colberg J.W., Catalona W.J. Surgical Management of Penile Cancer. Comprehensive Textbook of Genitourinary Oncology. 2nd Edition:2000;1057-1065
40. Pizzocaro G., Piva L., Nicolai N. Improved management of nodal metastases of squamous call carcinoma of the penis. Proc Am Urol Assoc. 153:1995;. Abstr 246A
41. Tanis P.J., Lont A.P., Meinhardt R.A., et al. Dynamic sentinel node biopsy for penile cancer reliability of a staging technique. J Urol. 168:2002;76-80
42. Gerbaulet A., Lambin P. Radiation therapy of cancer of the penis. Indications, advantages, and pitfalls. Urol Clin North Am. 19:1992;325-332
43. Elwell C.M., Jones W.G. Radiation Therapy for Penile Cancer. Comprehensive Textbook of Genitourinary Oncology. 2nd ed:2000;1065-1069 Lippincott Williams & Wilkins, Philadelphia, PA
44. McLean M., Akl A.M., Warde P., Bisset R., Panzella T., Gospodarowicz M. The Results of Primary Radiation Therapy in the Management of Squamous cell carcinoma of the Penis. Radiation Oncol Biol Phys. 25:1993;623-628
45. Crook J.M., Grimard L., Tsihlias J., et al. Interstitial brachytherapy for penile cancer an Alternative to Amputation. J Urol. 167:2002;506-511
46. rd ed:1997;1717-1731 Linpincott-Raven, New York
47. Grabstald H., Kelley C.D. Radiation therapy of penile cancer six to ten-year follow-up. Urology. 15:1980;575-576
48. Krieg R.M., Luk K.H. Carcinoma of penis. Review of cases treated by surgery and radiation therapy 1960-1977. Urology. 18:1981;149-154
49. Narayana A.S., Olney L.E., Loening S.A., Weimar G.W., Culp D.A. Carcinoma of the penis analysis of 219 cases. Cancer. 49:1982;2185-2191
50. Hardner G.J., Bhanalaph T., Murphy G.P., Moore R.H. Carcinoma of the penis Analysis of therapy in 100 consecutive cases. J Urol. 108:1972;428-431
51. Eisenberger M.A. Chemotherapy for carcinomas of the penis and urethra. Urol Clin of N America. 19:1992;333-338
52. Stadler W.M. Chemotherapy for Penile Cancer. Comprehensive Textbook of Genitourinary Oncology. 2nd ed:2000;1070-1072 Lippincott Williams & Wilkins, Philadelphia, PA
53. Connell C.F., Berger N.A. Management of advanced squamous cell carcinoma of the penis. Urol Clin North America. 21:1994;745-755
54. Shammas F.V., Ous S., Fossa S.D. Cisplatin and 5-Fluorouracil in advanced cancer of the penis. J Urol. 147:1992;630-632
55. Haas G.P., Blumenstein B.A., Gagliano R.G., et al. Cisplatin, Methotrexate and Bleomycin for the treatment of Carcinoma of the Penis A Southwest Oncology Group Study. J Urol. 161:1999;1823-1825
56. Corral D.A., Sella A., Pettaway C.A., Amato R.J., Jones D.M., Ellerhorst J. Combination Chemotherapy for Metastatic or Locally Advanced Genitourinary Squamous Cell Carcinoma A Phase II Study of Methotrexate, Cisplatin and Bleomycin. J Urol. 160:1998;1770-1774
57. Hussein A.M., Benedetto P., Sridhar K.S. Chemotherapy with Cisplatin and 5-Fluorouracil for Penile and Urethral Squamous Cell Carcinomas. Cancer. 65:1990;433-438
58. Ahmed T., Sklaroff R., Yagoda A. Sequential Trials of Methotrexate, Cisplatin and Bleomycin for Penile Cancer. J Urol. 132:1984;465-470
59. Kattan J., Culine S., Droz J.P., et al. Penile Cancer Chemotherapy Twelve Years' Experience at Institut Gustave-Roussy. Urology. 42:1993;559-562
60. Kyalwazis, Bhana D., Harrison N. Carcinoma of the Penis and Bleomycin Chemotherapy in Uganda. Br J Urol. 46:1974;689-696
61. Gagliano R., Blumenstein B., Crawford E., Stephens R.L., Coltman C.A., Costanzi J.J. CIS-diamminedichlorolatinum in the treatment of advanced epidermoid carcinoma of the penis A Southwest Oncology Group Study. J Urol. 141:1989;66-67
62. Roth A.D., Berney C.R., Rohner S., et al. Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal An active treatment modality with curative potential. Br J Cancer. 83:2000;1637-1642
63. Maiche A.G. Adjuvant treatment using bleomycin in squamous cell carcinoma of the penis study of 19 cases. Br J Urol. 55:1983;542-544
64. Pizzocaro G., Piva L. Adjuvant and neoadjuvant vincristine, bleomycin and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol. 27:1988;823-824
65. Fisher H.A.G., Baroda J.H., Horton J., Roemeling R.V. Neoadjuvant therapy with cisplatin and 5-fluorouracil for stage III squamous cell carcinoma of the penis. J Urol. 143:1990;352A. (Abstr 653)
66. Walsh T., Noonan N., Hollywood D., Kelley A., Keeling N., Hennessy T.P.J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467
67. Urba G., Orringer M., Turrisi A., Whyte R., Iannettoni M., Forastiere A. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer updated analysis. Proc Am Soc Clin Oncol. 16:1997;983. (Abstr 983)
68. Karen K., Fu. Combined modality therapy for head and neck cancer. Oncology. 11:1997;1-13
69. Chougule P., Wanebo H., Wallace A., et al. Concurrent paclitaxel, carboplatin and radiotherapy in advanced head and neck cancer a phase II study-preliminary results. Semin Oncol. 24:1997;S19-57-S19-61
70. Rich T.A., Ajani J.A., Morrison W.H., Ota D., Levin B. Chemoradiation therapy for anal cancer radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiotherapy Oncol. 27:1993;. 209-205
71. Choy H., Akerley W., Devore F. III. Concurrent paclitaaxel, carboplatin and radiation therapy for locally advanced non-small cell lung cancer. Semin Oncol. 26:(Suppl 2):1999;36-43
72. Choy H., Akerly H., Safran H., et al. Multi-institutional phase II trial of paclitaxel, carboplatin and concurrent radiation therapy for locally advanced non-small cell lung cancer. J Clin Oncol. 16:1998;3316-3322
73. Edsmyr F., Anderson L., Esposti P. Combined bleomycin and radiation in carcinoma of the penis. Cancer. 56:1985;1257-1263
74. Modig H., Duchek M., Sjodin J.G. Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol. 32:1993;653-655
75. Maiche A.G. Combined bleomycin and radiation treatment of penile carcinoma. Acta Oncol. 28:1989;548-549
76. Perez-Tamayot C., Wijnmaalen A., Pomp J., Van der Werf Messing B. Combined approach to squamous cell carcinoma of the penis. Proc Am Soc Clin Oncol. 6:1987;109. (Abstr 428)
77. Hainsworth J.D., Meluch A.A., Greco F.A. Paclitaxel, carboplatin and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies preliminary results of phase II trial. Semin Oncol. 24:1997;S19-38-S-19-42
78. Harden S.V., Tan L.T. Treatment of localized carcinoma of the penis A survey of current practice in the UK. Clin Oncol (R Coll Radiol). 13:2001;284-288
79. Rowinsky E.K. Signal transduction Inhibitors. Horizons in Cancer Therapeutics. 2:2001;3-35
80. Mendelsohn J. Blockade of Receptors for growth factors an anticancer therapy: the fourth annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Clinical Award lecture. Clin Can Res. 6:2000;747-753
81. Huang S.M., Bock J.M., Harari P.M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res. 59:1999;1935-1940
82. Hancock M.C., Langton B.C., Chan T., et al. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-Diamminedichloroplatinum against human breast and ovarian tumor cell lines. Cancer Res. 51:1991;4575-4580
83. Fan Z., Baselga J., Masui H., Mendelsohn J. Anti-tumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminechloroplatinum on well established A431 cell xenografts. Cancer Res. 53:1993;4637-4642
84. Ezekiel M.P., Robert F., Meredith R.F., et al. Phase I study of anti-epidermal growth factor receptor (EGFR) anti body C225 I combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck. (SCCIN). Proc Am Soc Clin Oncol. 17:1998;395. (Abstr 1522)
85. Ganly I., Eckhardt S.G., Rodriguez G.I., et al. A Phase I study of Onyx-015, an EIB attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin Cancer Res. 6:2000;798-806
86. Khuri F.R., Nemunaitis J., Ganly I., et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 6:2000;879-885